Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Thioredoxins | 3 | 2019 | 25 | 2.23 | Why? |
| Multiple Myeloma | 5 | 2018 | 1064 | 1.72 | Why? |
| Leukemia, Myeloid, Acute | 3 | 2018 | 676 | 1.08 | Why? |
| Reactive Oxygen Species | 4 | 2018 | 1136 | 0.91 | Why? |
| Thioredoxin-Disulfide Reductase | 1 | 2019 | 8 | 0.81 | Why? |
| Oxidative Stress | 3 | 2019 | 2050 | 0.79 | Why? |
| Peroxiredoxins | 1 | 2018 | 13 | 0.79 | Why? |
| Leukapheresis | 1 | 2018 | 20 | 0.73 | Why? |
| Selective Estrogen Receptor Modulators | 1 | 2018 | 65 | 0.71 | Why? |
| Raloxifene Hydrochloride | 1 | 2018 | 91 | 0.70 | Why? |
| COP9 Signalosome Complex | 1 | 2017 | 3 | 0.70 | Why? |
| Leukemia, Monocytic, Acute | 1 | 2017 | 8 | 0.69 | Why? |
| Immunotherapy | 4 | 2018 | 2421 | 0.65 | Why? |
| Apoptosis | 6 | 2018 | 2335 | 0.64 | Why? |
| Leukocytosis | 1 | 2018 | 280 | 0.60 | Why? |
| Cancer Vaccines | 1 | 2017 | 136 | 0.60 | Why? |
| Erythrocyte Indices | 1 | 2017 | 207 | 0.60 | Why? |
| Antigens, Neoplasm | 1 | 2017 | 230 | 0.59 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.57 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.56 | Why? |
| Leukemia | 1 | 2019 | 598 | 0.53 | Why? |
| Neoplasm Proteins | 1 | 2019 | 501 | 0.52 | Why? |
| Hematology | 1 | 2020 | 649 | 0.51 | Why? |
| Graft vs Host Disease | 1 | 2017 | 501 | 0.50 | Why? |
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 398 | 0.48 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.42 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.41 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.38 | Why? |
| Peptide Hydrolases | 1 | 2017 | 1269 | 0.38 | Why? |
| Killer Cells, Natural | 2 | 2020 | 2093 | 0.37 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.37 | Why? |
| Cell Proliferation | 5 | 2018 | 1973 | 0.36 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.35 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.32 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.32 | Why? |
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 1014 | 0.26 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.25 | Why? |
| Carcinoma, Hepatocellular | 3 | 2018 | 1222 | 0.25 | Why? |
| Drugs, Chinese Herbal | 1 | 2018 | 2760 | 0.25 | Why? |
| T-Lymphocytes | 2 | 2017 | 6670 | 0.24 | Why? |
| Liver Neoplasms | 3 | 2018 | 1666 | 0.22 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.22 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.21 | Why? |
| Receptors, Estrogen | 2 | 2018 | 171 | 0.21 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.20 | Why? |
| Kaplan-Meier Estimate | 3 | 2018 | 4260 | 0.20 | Why? |
| Multivariate Analysis | 3 | 2021 | 5440 | 0.20 | Why? |
| Larynx | 1 | 2020 | 126 | 0.20 | Why? |
| HL-60 Cells | 1 | 2018 | 60 | 0.19 | Why? |
| U937 Cells | 1 | 2018 | 77 | 0.19 | Why? |
| Serum Amyloid A Protein | 1 | 2020 | 211 | 0.19 | Why? |
| Phaeophyta | 1 | 2018 | 46 | 0.19 | Why? |
| Cephalosporins | 1 | 2021 | 250 | 0.19 | Why? |
| Sulfates | 1 | 2018 | 78 | 0.19 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.18 | Why? |
| Heterografts | 1 | 2018 | 203 | 0.18 | Why? |
| Mice, Inbred CBA | 1 | 2017 | 16 | 0.18 | Why? |
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2017 | 2 | 0.18 | Why? |
| Osteocytes | 1 | 2017 | 10 | 0.18 | Why? |
| Cesium Radioisotopes | 1 | 2017 | 7 | 0.18 | Why? |
| Estrogen Replacement Therapy | 1 | 2018 | 50 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.17 | Why? |
| Essential Hypertension | 1 | 2018 | 48 | 0.17 | Why? |
| RNA, Neoplasm | 1 | 2017 | 34 | 0.17 | Why? |
| Tumor Suppressor Proteins | 1 | 2018 | 165 | 0.17 | Why? |
| Tumor Cells, Cultured | 1 | 2017 | 254 | 0.17 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.17 | Why? |
| Microscopy, Confocal | 1 | 2018 | 343 | 0.17 | Why? |
| Osteoblasts | 1 | 2017 | 87 | 0.16 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.16 | Why? |
| Endogenous Retroviruses | 1 | 2016 | 72 | 0.16 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.16 | Why? |
| Nucleic Acids | 1 | 2021 | 435 | 0.16 | Why? |
| Postmenopause | 1 | 2018 | 160 | 0.16 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.16 | Why? |
| Bone Diseases | 1 | 2017 | 101 | 0.15 | Why? |
| Tumor Microenvironment | 1 | 2018 | 264 | 0.15 | Why? |
| Dual Specificity Phosphatase 1 | 1 | 2015 | 11 | 0.15 | Why? |
| T-Lymphocytes, Cytotoxic | 2 | 2017 | 552 | 0.15 | Why? |
| Perimenopause | 1 | 2015 | 14 | 0.15 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.15 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.15 | Why? |
| Cytotoxicity, Immunologic | 1 | 2017 | 287 | 0.15 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.15 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.14 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 133 | 0.14 | Why? |
| Cell Line, Tumor | 3 | 2018 | 3608 | 0.14 | Why? |
| Bone Marrow Transplantation | 1 | 2017 | 343 | 0.13 | Why? |
| Signal Transduction | 4 | 2018 | 7207 | 0.13 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.13 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.13 | Why? |
| Neoplasm Staging | 2 | 2017 | 1999 | 0.13 | Why? |
| Estradiol | 1 | 2015 | 250 | 0.13 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.13 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.13 | Why? |
| Animals | 7 | 2018 | 78931 | 0.12 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.12 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.12 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| China | 6 | 2021 | 50654 | 0.12 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.12 | Why? |
| Circadian Rhythm | 1 | 2018 | 607 | 0.11 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Female | 17 | 2021 | 380317 | 0.11 | Why? |
| Aged | 12 | 2021 | 215776 | 0.11 | Why? |
| Neoplasms | 4 | 2021 | 17251 | 0.11 | Why? |
| Humans | 28 | 2021 | 930598 | 0.11 | Why? |
| Polysaccharides | 1 | 2018 | 854 | 0.11 | Why? |
| Depressive Disorder, Major | 2 | 2017 | 852 | 0.11 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.11 | Why? |
| Hand Disinfection | 1 | 2020 | 1671 | 0.10 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.10 | Why? |
| Mice | 3 | 2018 | 21357 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Testosterone | 1 | 2015 | 596 | 0.10 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.10 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| ROC Curve | 2 | 2017 | 6024 | 0.09 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.09 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.09 | Why? |
| Depression | 2 | 2015 | 14116 | 0.08 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.08 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.08 | Why? |
| Male | 12 | 2021 | 367725 | 0.08 | Why? |
| Adult | 10 | 2021 | 244371 | 0.08 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.08 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.08 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.08 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.08 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.08 | Why? |
| Superoxide Dismutase | 1 | 2006 | 155 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2017 | 2262 | 0.08 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.06 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.06 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.06 | Why? |
| Complement C1q | 1 | 2020 | 31 | 0.05 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 526 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Child | 3 | 2021 | 70012 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Radiation Tolerance | 1 | 2018 | 25 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.04 | Why? |
| Killer Cells, Lymphokine-Activated | 1 | 2017 | 3 | 0.04 | Why? |
| Receptors, Antigen | 1 | 2017 | 5 | 0.04 | Why? |
| Molecular Conformation | 1 | 2018 | 374 | 0.04 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2018 | 126 | 0.04 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.04 | Why? |
| Receptors, Progesterone | 1 | 2017 | 76 | 0.04 | Why? |
| fas Receptor | 1 | 2017 | 85 | 0.04 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.04 | Why? |
| Certification | 1 | 2020 | 261 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Neoplastic Stem Cells | 1 | 2018 | 120 | 0.04 | Why? |
| Caspase 8 | 1 | 2017 | 92 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2017 | 207 | 0.04 | Why? |
| Receptor, ErbB-2 | 1 | 2017 | 267 | 0.04 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2018 | 242 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| Angiogenesis Inhibitors | 1 | 2018 | 395 | 0.03 | Why? |
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 341 | 0.03 | Why? |
| Single-Chain Antibodies | 1 | 2017 | 259 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2021 | 987 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Analysis of Variance | 1 | 2015 | 950 | 0.03 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2017 | 760 | 0.03 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.03 | Why? |
| Hospitals, Pediatric | 1 | 2021 | 1792 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Psychiatric Status Rating Scales | 1 | 2015 | 1340 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2016 | 1314 | 0.02 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2016 | 1810 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2016 | 11304 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2015 | 8495 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Case-Control Studies | 1 | 2015 | 17671 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
Zhou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(212)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(132)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_